Canaccord Genuity Reiterates Hold Rating on Vertex Pharmaceuticals Incorporated (VRTX)
Rating Change Canaccord Genuity analysts reiterated a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals…
Read more
